REG - Venture Life Group - Director/PDMR Shareholding

Venture LifeAnnouncement

09/12/2020 14:30

RNS Number : 1158I
  
Venture Life Group PLC
  
09 December 2020
  
 

9 December 2020
Venture Life Group plc
("Venture Life" or the "Company")
PDMR Dealings and Issue of Equity
Further to the announcements made on 20 November 2020, 24 November and 8 December the Company confirms completion of the sale of an aggregate 8,173,343 Sale Shares and the Exercise of 1,735,744  EMI Options.  The details of these transactions are set out below.
The Company further notifies that on 9 December 2020 Jerry Randall and Sharon Daly (nee Collins) sold 1,231,852 and 418,779 Ordinary Shares at a price of 90 pence per share respectively.  The Company also notifies that on the 9 December 2020, that Mrs A. Randall, wife of Jerry Randall, acquired 1,231,852 Ordinary Shares at a price of 90.01 pence per Ordinary Share and Mr C. Daly, husband of Sharon Daly (nee Collins), acquired 418,779 Ordinary Shares at a price of 90.01 pence per Ordinary Share.
As a result of these transactions, the respective interests in the voting rights of the Company of Jerry Randall and Sharon Daly (nee Collins) remained unchanged and are as follows:
 



Director Name


No. of Sale Shares Sold at 90 p per share


EMI options exercised


EMI Option Exercise price


Resultant shareholding post transactions


% of voting rights post transactions.




Jerry Randall


2,752,751


705,700
162,187


45p per share
41p per share
 


1,844,865*


1.5%




Sharon Daly


1,877,863


705,700
162,187


45p per share
41p per share
 


1,009,977**


0.8%




Gianluca Braguti and certain of his associates.


3,542,729


NA


NA


3542,730


2.8%



 
* Of which Jerry Randall retains the beneficial interest 653,013 Ordinary Shares with the remaining 1,231,852 held by his wife, Mrs A. Randall.
** Of which Sharon Daly retains the beneficial interest in 591,197 Ordinary Shares with the remaining 418,779 being held by her husband, Mr C. Daly.
Capitalised terms used, but not defined, in this announcement have the same meaning as set out in the Circular.
For further information, please contact:
Venture Life Group PLC    +44 (0) 1344 578004

Jerry Randall, Chief Executive Officer

Andrew Waters, Chief Financial Officer
Cenkos Securities plc (Nomad and Joint Broker)    +44 (0) 20 7397 8900

Stephen Keys / Camilla Hume/ (Corporate Finance)

Russell Kerr / Michael Johnson (Sales)
N+1 Singer (Joint Broker)
Shaun Dobson / Carlo Spingardi (Corporate Finance)      +44 (0) 20 7496 3000

Jonathan Dighe (Sales)    
About Venture Life ( www.venture-life.com )
Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market. With operations in the UK, The Netherlands and Italy, the Group's product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women's intimate healthcare, fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.
The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples. In the UK and The Netherlands these are supplied direct by the company to retailers, elsewhere they are supplied by the Group's international distribution partners.
Through its Development & Manufacturing business in Italy, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.
The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:



 1


Details of the person discharging managerial responsibilities / person closely associated  




a)


Name


1.    Jerry Randall
 




2


Reason for the notification




a)


Position/status


1.    Chief Executive Officer
 




b)


Initial notification /Amendment


Further Notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 




a)


Name


Venture Life Group plc




b)


LEI


213800S8CZUPLAB2KC70




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument


Ordinary Shares of 0.3p each in Venture Life Group plc




b)


Identification code 


GB00BFPM8908




c)


Nature of the transaction 


Exercise of EMI Share Options and Sales of Ordinary Shares




d)
 


Price and volumes


1.    Sale of 2,752,751 Ordinary Shares at a price of £0.90
2.    705,700 options exercised at a price of £0.45 per Ordinary Share and 162,187 options exercised at a price of £0.41 per Ordinary Share.
3.    Sale of 1,231,852 Ordinary Shares at a price of £0.90
 




e)
 


Aggregated information 
- Aggregated volume
- Price


 See above
 




f)


Date of the transaction 


9 December




g)


Place of the transaction


London Stock Exchange



 
 



 1


Details of the person discharging managerial responsibilities / person closely associated  




a)


Name


2.    Anne Randall
 




2


Reason for the notification




a)


Position/status


PCA to Jerry Randall, Chief Executive Officer
 




b)


Initial notification /Amendment


Initial Notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 




a)


Name


Venture Life Group plc




b)


LEI


213800S8CZUPLAB2KC70




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument


Ordinary Shares of 0.3p each in Venture Life Group plc




b)


Identification code 


GB00BFPM8908




c)


Nature of the transaction 


Exercise of EMI Share Options and Sales of Ordinary Shares




d)
 


Price and volumes


Purchase of 1,231,852 Ordinary Shares at a price of £0.9001
 




e)
 


Aggregated information 
- Aggregated volume
- Price


 See above
 




f)


Date of the transaction 


9 December




g)


Place of the transaction


London Stock Exchange



 



 1


Details of the person discharging managerial responsibilities / person closely associated  




a)


Name


3.    Sharon Daly
 




2


Reason for the notification




a)


Position/status


Chief Commercial Officer 
 




b)


Initial notification /Amendment


Further Notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 




a)


Name


Venture Life Group plc




b)


LEI


213800S8CZUPLAB2KC70




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument


Ordinary Shares of 0.3p each in Venture Life Group plc




b)


Identification code 


GB00BFPM8908




c)


Nature of the transaction 


Exercise of EMI Share Options and Sales of Ordinary Shares




d)
 


Price and volumes


1.    Sale of 1,877,863 ordinary shares at a price of £0.90 per Ordinary Share 
2.    705,700 options exercised at a price of £0.45 per Ordinary Share and 162,187 options exercised at a price of £0.41 per Ordinary Share.
3.    Sale of 418,779 Ordinary Shares at a price of £0.90
 
 
 




e)
 


Aggregated information 
- Aggregated volume
- Price


 See above
 




f)


Date of the transaction 


9 December 2020




g)


Place of the transaction


London Stock Exchange



 
 



 1


Details of the person discharging managerial responsibilities / person closely associated  




a)


Name


4.    Chris Daly
 




2


Reason for the notification




a)


Position/status


PCA to Sharon Daly, Chief Commercial Officer 
 




b)


Initial notification /Amendment


Initial Notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 




a)


Name


Venture Life Group plc




b)


LEI


213800S8CZUPLAB2KC70




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument


Ordinary Shares of 0.3p each in Venture Life Group plc




b)


Identification code 


GB00BFPM8908




c)


Nature of the transaction 


Exercise of EMI Share Options and Sales of Ordinary Shares




d)
 


Price and volumes


Purchase of 418,779 Ordinary Shares at a price of £0.9001
 
 
 




e)
 


Aggregated information 
- Aggregated volume
- Price


 See above
 




f)


Date of the transaction 


9 December 2020




g)


Place of the transaction


London Stock Exchange



 
 
 
 



 1


Details of the person discharging managerial responsibilities / person closely associated  




a)


Name


5.    Gianluca Braguti and certain of his associates




2


Reason for the notification




a)


Position/status


Chief Manufacturing Officer




b)


Initial notification /Amendment


Further Notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 




a)


Name


Venture Life Group plc




b)


LEI


213800S8CZUPLAB2KC70




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument


Ordinary Shares of 0.3p each in Venture Life Group plc




b)


Identification code 


GB00BFPM8908




c)


Nature of the transaction 


Sales of Ordinary Shares




d)
 


Price and volumes


Sale of 3,542,729 ordinary shares at a price of £0.90 per Ordinary Share




e)
 


Aggregated information 
- Aggregated volume
- Price


 See above
 




f)


Date of the transaction 


9 December 2020




g)


Place of the transaction


London Stock Exchange



 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
DSHFLFFSFDLAIII